General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors
暂无分享,去创建一个
[1] Cynthia Ludwig,et al. Gastrointestinal tract , 2005, The American Journal of Digestive Diseases.
[2] P. Srivastava,et al. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70 , 2001, European journal of immunology.
[3] S. Kitano,et al. Pathology and prognosis of gastric carcinoma , 2000, Cancer.
[4] S. Song,et al. An immunohistochemical analysis of heat shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix. , 1999, Gynecologic oncology.
[5] Y. Doki,et al. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus , 1999, Cancer.
[6] Hyung Sik Kim,et al. Association of Helicobacter pylori Infection with Gastric Adenocarcinoma , 1998, Japanese journal of cancer research : Gann.
[7] M. Go. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? , 1997, Gastroenterology.
[8] M. Asaka,et al. What role does Helicobacter pylori play in gastric cancer? , 1997, Gastroenterology.
[9] E. El-Omar,et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. , 1997, Gastroenterology.
[10] M. A. Sáez,et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma , 1997, Cancer.
[11] R. Issels,et al. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. , 1997, Journal of immunology.
[12] V. Kosma,et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. , 1996, British Journal of Cancer.
[13] W. Chang,et al. IMMUNOCYTOCHEMICAL EXPRESSION OF THE 70 kD HEAT SHOCK PROTEIN IN ISCHAEMIC BOWEL DISEASE , 1996, The Journal of pathology.
[14] Julie Brittenden,et al. Natural killer cells and cancer , 1996, Cancer.
[15] T. Shibata,et al. Helicobacter pylori infection in patients with gastric carcinoma in biopsy and surgical resection specimens , 1996, Cancer.
[16] P. Stravoravdi,et al. Natural killer cell activation after interferon administration in patients with metastatic renal cell carcinoma: an ultrastructural and immunohistochemical study. , 1996, European urology.
[17] H. Inoue,et al. Lymphokine‐activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients , 1994, Clinical and experimental immunology.
[18] T. Nevalainen,et al. Epidemiology of intestinal and diffuse types of gastric carcinoma a time‐trend study in finland with comparison between studies from high‐ and low‐risk areas , 1993, Cancer.
[19] D R Ciocca,et al. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. , 1993, Journal of the National Cancer Institute.
[20] J. Raus,et al. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. , 1992, Anticancer research.
[21] T. Yao,et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy , 1992, Cancer.
[22] M. Teh,et al. Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia, and tumour histology. , 1992, Gut.
[23] H. Adami,et al. Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951. , 1991, British Journal of Cancer.
[24] W. Karnes,et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. , 1991, Gastroenterology.
[25] M. Kikuchi,et al. Changes in gastric mucosa that antedate gastric carcinoma , 1990, Cancer.
[26] R. Sassatelli,et al. Familial occurrence of gastric cancer in the 2‐year experience of a population‐based registry , 1990, Cancer.
[27] J. Pezzullo,et al. Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications. , 1990, Human pathology.
[28] J. Kitinya,et al. Epidemiology of intestinal and diffuse types of gastric carcinoma in the Mount Kilimanjaro area, Tanzania. , 1988, African journal of medicine and medical sciences.
[29] J. Monson,et al. Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer. , 1987, Gut.
[30] K. Yamaguchi,et al. Statistical analysis of the surgical materials of stomach cancer in Japan , 1987, Cancer.
[31] T. Hattori. Development of adenocarcinomas in the stomach , 1986, Cancer.
[32] Jie-fei Huang,et al. Sulphomucin colonic type intestinal metaplasia and carcinoma in the stomach. A histochemical study of 115 cases obtained by biopsy , 1986, Cancer.
[33] B. Gazzard,et al. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. , 1985, Gut.
[34] D. Owen,et al. Carcinoma of the stomach in young persons , 1985, Cancer.
[35] E. Holmes. Immunology of Tumor Infiltrating Lymphocytes , 1985, Annals of surgery.
[36] Y. Kondō,et al. Intestinal metaplasia of the regenerative epithelia in 549 gastric ulcers. , 1983, Human pathology.
[37] P. Sipponen,et al. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample , 1983, Cancer.
[38] F. Iida,et al. Gastric carcinoma and intestinal metaplasia significance of types of intestinal metaplasia upon development of gastric carcinoma , 1982, Cancer.
[39] D. Antonioli,et al. Changes in the location and type of gastric adenocarcinoma , 1982, Cancer.
[40] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[41] J. Efskind,et al. The pathology and prognosis of gastric carcinoma. , 1960, Acta chirurgica Scandinavica. Supplementum.
[42] William E. Neville,et al. Gastrointestinal Tract , 1959 .